share_log

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

产业联盟以投机性买入评级启动对NervGen Pharma的覆盖,宣布目标价为6美元
Benzinga Real-time News ·  2021/07/13 08:55

Industrial Alliance initiates coverage on NervGen Pharma (OTC:NGENF) with a Speculative Buy rating and announces Price Target of $6.

工业联盟以投机性买入评级启动对NervGen Pharma(场外交易代码:NGENF)的保险,并宣布目标价为6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发